GoldenGolden
Advanced Search
Alexandria Real Estate Equities

Alexandria Real Estate Equities

A private equity firm focused on real estate investments involved in the cluster formation of science based companies primarily operating in the life science industry.

Alexandria Real Estate Equities is a private equity firm focused on real estate investments involved in the cluster formation of science based companies primarily operating in the life science industry that is headquartered in Pasadena, California and was founded in 1994 by Joel Marcus.

Company Overview

Alexandria Venture Investments operates as a private equity firm. The Company focuses on commercial and residential properties. Alexandria Venture Investments serves clients in the United States.

History

Founded in 1996, Alexandria Venture Investments is a corporate venture arm of Alexandria Real Estate Equities.

The firm invests in seed and early-stage businesses operating in the life science, healthcare, food, agriculture, and biotechnology sectors.

Alexandria Venture Investments, the strategic investment arm of Alexandria Center® at Kendall Square, is involved in innovation and entrepreneurship by investing capital in diverse science and technology sectors.The firm provides strategic investment capital to innovative life science and technology entities developing breakthrough therapies and technologies.

Investments

Alongside commercial and residential properties, Alexandria also focuses on biotechnology investments.

Alexandria Venture Investments has made over 50 investments. A large investment was made on Jan 30, 2019, when they invested $60M in Dewpoint Therapeutics.

Alexandria Venture Investments has had 10 exits. Alexandria Venture Investments's most notable exits include TCR2, Moderna Therapeutics, and Gritstone Oncology.

Timeline

February 14, 2019
Obsidian Therapeutics

Obsidian Therapeutics

$49,500,000

VENTURE CAPITAL (SERIES A)

February 14, 2019
TCR2 Therapeutics Inc.

$125,000,000

VENTURE CAPITAL (SERIES B)

January 7, 2019
GreenLight Bio

$50,000,000

VENTURE CAPITAL (SERIES E)

January 3, 2019
Immusoft Corporation

$20,000,000

VENTURE CAPITAL (SERIES B)

October 9, 2018
Gotham Therapeutics

$54,000,000

VENTURE CAPITAL (SERIES A)

September 10, 2018
OncoResponse

$40,000,000

VENTURE CAPITAL (SERIES B)

September 9, 2018
Benson Hill Biosystems

$60,000,000

VENTURE CAPITAL (SERIES C)

August 8, 2018
Inari

$40,000,000

VENTURE CAPITAL (SERIES B)

July 11, 2018
Compass Therapeutics

$127,500,000

VENTURE CAPITAL (SERIES A)

July 11, 2018
ORIG3N

VENTURE CAPITAL (SERIES B)

Page 1 of 4

People

Further reading

Documentaries, videos and podcasts

Companies

News

Title
Author
Date
Publisher
Description
Alexandria Real Estate Equities, Inc.
June 17, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the closing of its previously announced...
Alexandria Real Estate Equities, Inc.
June 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public offering of...
Alexandria Real Estate Equities, Inc.
June 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public...
Alexandria Real Estate Equities, Inc.
June 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and...
Alexandria Real Estate Equities, Inc.
April 26, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the first quarter ended March 31, 2021. Key...
Center for Active Design
March 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- The Center for Active Design (CfAD) today announced the 2021 winners of the Fitwel Best in Building Health Awards®, its flagship recognition...
Alexandria Real Estate Equities, Inc.
February 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) announced today that it has priced the previously announced...
Alexandria Real Estate Equities, Inc.
February 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of...
Alexandria Real Estate Equities, Inc.
February 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has commenced a cash tender offer for...
Alexandria Real Estate Equities, Inc.
February 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public...
Alexandria Real Estate Equities, Inc.
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the fourth quarter and year ended December 31,...
FUJIFILM Diosynth Biotechnologies
January 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- FUJIFILM Corporation (COO: Kenji Sukeno) and the Center for Advanced Biological Innovation and Manufacturing (CABIM), today announced that it...
Alexandria Real Estate Equities, Inc.
January 6, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public offering of...
Alexandria Real Estate Equities, Inc.
January 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.